Blueshift Asset Management, LLC Biomarin Pharmaceutical Inc Transaction History

Blueshift Asset Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$82.16 - $96.94 $207,289 - $244,579	2,523 New	2,523 $214,000
Q2 2022 Aug 12, 2022	SELL	$71.48 - $86.85 $589,209 - $715,904	-8,243 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$74.28 - $92.69 $612,290 - $764,043	8,243 New	8,243 $636,000
Q2 2021 Aug 13, 2021	SELL	$75.51 - $84.79 $789,457 - $886,479	-10,455 Closed	0 $0
Q1 2021 May 06, 2021	BUY	$74.73 - $90.69 $781,302 - $948,163	10,455 New	10,455 $789,000

632

185M

1.63M

1.2M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $13.1B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Blueshift Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Blueshift Asset Management, LLC with notifications on news.